Causality

Dorney Park & Wildwater Kingdom to Host Iron Menace Ride for a Cause Event to Benefit Eagles Autism Foundation

Retrieved on: 
Thursday, March 28, 2024

Dorney Park is hosting an Iron Menace Ride for a Cause event benefiting the Eagles Autism Foundation on Friday, April 19, from 5pm – 9pm at Dorney Park.

Key Points: 
  • Dorney Park is hosting an Iron Menace Ride for a Cause event benefiting the Eagles Autism Foundation on Friday, April 19, from 5pm – 9pm at Dorney Park.
  • Dorney Park has chosen the Eagles Autism Foundation to be the charitable beneficiary for this event.
  • “Dorney Park is proud to share the spotlight created by excitement and enthusiasm for our new roller coaster Iron Menace with the Eagles Autism Foundation,” said Dorney Park Vice President and General Manager Jessica Naderman.
  • Dorney Park and the Eagles Autism Foundation are partnering with illustrator and Allentown artist Ryan Lynn.

Saratoga Rotary Club Hosts Annual Art Show May 4-5, 2024

Retrieved on: 
Thursday, April 4, 2024

The Rotary Club of Saratoga is hosting its annual Art Show on May 4-5, 2024 at West Valley College and, for the first time, a 5K Run/Walk For a Cause race to benefit local charities.

Key Points: 
  • The Rotary Club of Saratoga is hosting its annual Art Show on May 4-5, 2024 at West Valley College and, for the first time, a 5K Run/Walk For a Cause race to benefit local charities.
  • The Art Show will be open 10 a.m. to 5 p.m. on both Saturday and Sunday.
  • Every year, the Art Show draws art lovers and collectors from all over the Bay Area to visit and purchase one-of-a-kind creations directly from artists .
  • A portion of the art sales proceeds benefit the Saratoga Rotary Charitable Foundation.

Cybin Receives FDA Breakthrough Therapy Designation for its Novel Psychedelic Molecule CYB003 and Announces Positive Four-Month Durability Data in Major Depressive Disorder

Retrieved on: 
Wednesday, March 13, 2024

If approved by the FDA, CYB003 would be the first known adjunctive psychedelic-based therapeutic for the treatment of MDD.

Key Points: 
  • If approved by the FDA, CYB003 would be the first known adjunctive psychedelic-based therapeutic for the treatment of MDD.
  • The designation of CYB003 as a breakthrough therapy acknowledges the significant unmet medical need for more effective treatments of MDD and supports CYB003’s potential for significant improvements over existing therapies.
  • With the robust durability data from our Phase 2 study in hand, we are ready to move forward expeditiously.
  • (2022) Response to acute monotherapy for major depressive disorder in randomized, placebo-controlled trials submitted to the US Food and Drug Administration: individual participant data analysis.

Parental avoidance of toxic exposures could help prevent autism, ADHD in children, new study shows

Retrieved on: 
Thursday, March 28, 2024

SAN ANTONIO, March 27, 2024 /PRNewswire-PRWeb/ -- Autism and attention deficit hyperactivity disorder (ADHD) may be preventable if parents avoid toxic exposures and adopt interventions such as environmental house calls, according to a published study led by researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio).

Key Points: 
  • The findings build on a 2015 study by UT Health San Antonio that first linked chemical intolerance in patients with the risk of their children developing autism and ADHD.
  • "Up to now, most interventions have been behavioral or medical, after a child is diagnosed."
  • Still, they wrote, "The implications of this study, if confirmed, could be significant for preventive measures and early intervention strategies in families with parental chemical intolerance.
  • And the prevalence of ADHD has risen to one in eight children, also according to the CDC.

Causal IQ Recognized by Campaigns & Elections for Exceptional Work in Digital Advertising

Retrieved on: 
Tuesday, March 26, 2024

Named for Campaigns & Elections founder Stanley Foster Reed, The Reed Awards embody excellence in political campaigning and grassroots & advocacy.

Key Points: 
  • Named for Campaigns & Elections founder Stanley Foster Reed, The Reed Awards embody excellence in political campaigning and grassroots & advocacy.
  • Causal IQ was recognized in the categories of Best Use of Online Targeting for Mayoral Campaign and Best Use of Digital Out of Home (DOOH) for its exemplary work during the 2023 political season.
  • "We are incredibly honored to receive these prestigious accolades," said Ryan Ray, Regional Vice President of Media Sales at Causal IQ. "
  • Causal IQ's award-winning campaigns demonstrated the company's proficiency in leveraging advanced targeting techniques and digital out-of-home advertising to deliver impactful results for political campaigns.

Causaility Launches Causaition™ Biomimetic AI Digital Twin Solution

Retrieved on: 
Wednesday, March 20, 2024

DENVER, March 20, 2024 /PRNewswire/ -- Causaility, LLC today announces the launch of its Denver-based headquarters and availability of Causaition™, a revolutionary Biomimetic AI Digital Twin Solution that enables healthcare, communications, financial services, and other organizations to explore knowledge hidden within their dark and disparate data.

Key Points: 
  • DENVER, March 20, 2024 /PRNewswire/ -- Causaility, LLC today announces the launch of its Denver-based headquarters and availability of Causaition ™, a revolutionary Biomimetic AI Digital Twin Solution that enables healthcare, communications, financial services, and other organizations to explore knowledge hidden within their dark and disparate data.
  • Causaition solutions are built on biomimetic AI innovator RYLTI's patent-pending RYAILITI Knowledge Engineering (RKE) Biomimetic AI Platform and Digital Twin Ecosystem.
  • Causaition solutions uniquely reveal valuable insights from within dark data by discovering the unrealized nexus of connections, relationships, and interactions across data silos.
  • Causaition's core solutions incorporate our transformative RYAILITI Knowledge Engineering (RKE) Biomimetic AI Platform and Digital Twin Ecosystem, which can dramatically accelerate discovery and uncover dark data discoveries with insights never-before-achievable," said Peter Fiorillo, Co-founder and CEO of RYLTI.

Causal IQ Announces Strategic Partnership with The Philly Ad Club to Advance Community Impact and Innovation

Retrieved on: 
Monday, March 11, 2024

LOS ANGELES, March 11, 2024 /PRNewswire/ -- Causal IQ, a leading programmatic solutions provider, and The Philly Ad Club, Philadelphia's premier marketing organization, have entered into a strategic partnership aimed at advancing community impact and fostering innovation in the industry.

Key Points: 
  • LOS ANGELES, March 11, 2024 /PRNewswire/ -- Causal IQ, a leading programmatic solutions provider, and The Philly Ad Club, Philadelphia's premier marketing organization, have entered into a strategic partnership aimed at advancing community impact and fostering innovation in the industry.
  • "It is truly an honor to have the opportunity to serve in a volunteer leadership role with the Philly Ad Club.
  • Recently, Causal IQ presented at The Philly Ad Club's Impact and Innovation AI Summit, exploring the transformative power of A.I.
  • This engagement underscores the shared commitment of Causal IQ and The Philly Ad Club to navigate the ever-evolving landscape of marketing and advertising, driving innovation and impact every step of the way.

How have households adjusted their spending and saving behaviour to cope with high inflation?

Retrieved on: 
Wednesday, April 3, 2024

The findings suggest that households have primarily adjusted their consumption spending to cope with higher inflation.

Key Points: 
  • The findings suggest that households have primarily adjusted their consumption spending to cope with higher inflation.
  • The decline in the saving rate in 2022 and 2023 was mainly attributed to increased spending on recreation and travel, mostly driven by high-income consumers.

BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)

Retrieved on: 
Tuesday, February 27, 2024

Approximately 80 sites in the US, Canada, UK and the EU, including Belgium, France, Italy, Germany, Netherlands, Spain and others will conduct the study.

Key Points: 
  • Approximately 80 sites in the US, Canada, UK and the EU, including Belgium, France, Italy, Germany, Netherlands, Spain and others will conduct the study.
  • The planned primary outcomes are all-cause mortality at Day 28 between treatment groups and incidence, causality, and severity of SAEs in rhu-pGSN vs placebo treatment.
  • Breathing becomes difficult and patients require oxygen, mechanical ventilation and extensive critical care resources, placing a significant burden on the healthcare system.
  • In the U.S. alone, ARDS affects over 700,000 patients per year or roughly 10% of all ICU admissions.

Call for Entries Issued for The 21st Annual International Business Awards®

Retrieved on: 
Thursday, February 22, 2024

There are many new and revised features of The International Business Awards for 2024:

Key Points: 
  • There are many new and revised features of The International Business Awards for 2024:
    There are a variety of new Technology Solution Categories for Artificial Intelligence and Machine Learning Solutions, split into subcategories for Financial, Generative (audio, graphics, text, video), Healthcare, and other solutions.
  • There are additional new technology categories for Cybersecurity, Digital Asset Management, Digital Employee Experience, and Knowledge Center/Help Sites.
  • There are many new Event Categories for Cause & Green Events including CSR Experience, Employee Giving & Volunteerism, Inclusive Events, and other Brand Experiences/Events by type including Gamified Experience, Pop-Up Experience, and Immersive Experience.
  • There are new categories sprinkled throughout the category groups for New Product & Product Management Awards, Mobile Site & App Awards , and Website Awards.